Maria Alexandersson

Statistics

Publications

Citations

325

H-Index

Active since

1997

Affiliations

AstraZeneca (Sweden)(Current)

Maria Alexandersson is an author at AstraZeneca (Sweden) specializing in pharmacology, adipocyte insulin signaling, and peroxisome proliferator-activated receptors.

Publications per year

1997–2018

Publications

Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

Ulrika Edvardsson, Monica Bergström, Maria Alexandersson et al. · Journal of Lipid Research · 1999 · 125 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Evidence for nitric oxide mediation of contractile activity in isolated strips of the human Fallopian tube

Erling Ekerhovd, Mats Brännström, Maria Alexandersson et al. · Human Reproduction · 1997 · 73 citations · Full text

Life Sciences, Pharmacology, Physiology +13

A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643

Ulrika Edvardsson, Maria Alexandersson, Helena Brockenhuus von Löwenhielm et al. · Electrophoresis · 1999 · 64 citations

Life Sciences, Biochemistry, Pharmacology +17

A small difference in recovery between total knee arthroplasty with and without tourniquet use the first 3 months after surgery: a randomized controlled study

Maria Alexandersson, Eugen Yuhui Wang, Staffan Eriksson · Knee Surgery Sports Traumatology Arthroscopy · 2018 · 63 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +17

1–4 of 4